Project Veritas released a shocking video of a Food and Drug Administration (FDA) official advocating for the government use of drones to “blow dart” COVID-19 vaccines into black people and vaccine resisters.
In a disturbing video by Project Veritas, an effeminate FDA official told an undercover journalist that the government should use drones to “blow darts” of the COVID-19 vaccine into black people and vaccine resisters, signaling his support for a Nazi-style registry for the unvaccinated. “That’s where we’re going,” said the FDA’s Taylor Lee.“Census goes door-to-door if you don’t respond. So, we have the infrastructure to do it [forced COVID vaccinations]. I mean, it’ll cost a ton of money,” Taylor said. “But I think, at that point, I think there needs to be a registry of people who aren’t vaccinated. Although that’s sounding very [much like Nazi] Germany.”
“Nazi Germany…I mean, think about it like the Jewish Star [for unvaccinated Americans],” he said. “So, if you put every anti-vaxxer, like sheep, into like Texas and you closed off Texas from the rest of the world, and you go, ‘Okay, you be you in Texas until we deal with this [pandemic].’”
On August 23rd all the mainstream or agitprop media outlets were trumpeting the news that the FDA had granted permanent approval for the Pfizer Covid-19 vaccine. The press breathlessly reported that vaccine mandates were now legal for healthcare workers, employees in private industry, college students, and government employees at all levels including teachers and school staff.
Almost immediately Joe Biden shuffled his way to the podium and read off his teleprompter that all businesses should immediately institute vaccine mandates. The Pentagon announced that vaccinations would be mandatory for all active service members. Bill de Blasio immediately instituted a vaccine mandate for all New York City teachers and staff.
But what the agitprop media and the Biden White House failed to report is that there are two critical issues as to whether the Pfizer-BioNTech Covid vaccine (which is what has been and continues to be administered) can be mandated and whether Pfizer can be held liable for injuries, a provision that accompanies permanent approval of a vaccine or drug.
What the FDA approved and licensed is Pfizer’s Comirnaty Covid vaccine not the current Pfizer-BioNTech Covid vaccine in use under an Emergency Use Authorization (EUA). The FDA has acknowledged that Pfizer has insufficient stocks of the newly licensed Comirnaty vaccine available but there is a significant amount of the Pfizer-BioNTech Covid vaccine available under the EUA still on hand.
Further, the FDA decreed that the Pfizer-BioNTech vaccine should remain unlicensed and under the EUA but can be used interchangeably with the newly licensed Comirnaty vaccine. More importantly, the FDA states that the licensed Comirnaty vaccine and the existing Pfizer-BioNTech vaccine are “legally distinct” but proclaims that their differences do not “impact safety or effectiveness.” [emphases added]
The press reported that vaccine mandates are now legal for military, healthcare workers, college students and employees in many industries. New York City Mayor Bill de Blasio has now required the vaccine for all teachers and school staff. The Pentagon is proceeding with its mandate for all military service members.
But there are several bizarre aspects to the FDA approval that will prove confusing to those not familiar with the pervasiveness of the FDA’s regulatory capture, or the depths of the agency’s cynicism.
First, the FDA acknowledges that while Pfizer has “insufficient stocks” of the newly licensed Comirnaty vaccine available, there is “a significant amount” of the Pfizer-BioNTech COVID vaccine — produced under Emergency Use Authorization (EUA) — still available for use.
The FDA decrees that the Pfizer-BioNTech vaccine under the EUA should remain unlicensed but can be used “interchangeably” (page 2, footnote 8) with the newly licensed Comirnaty product.ORDER TODAY: Robert F. Kennedy, Jr.’s New Book — ‘The Real Anthony Fauci’
Second, the FDA pointed out that the licensed Pfizer Comirnaty vaccine and the existing, EUA Pfizer vaccine are “legally distinct,” but proclaims that their differences do not “impact safety or effectiveness.”
There is a huge real-world difference between products approved under EUA compared with those the FDA has fully licensed.
EUA products are experimental under U.S. law. Both the Nuremberg Code and federal regulations provide that no one can force a human being to participate in this experiment. Under 21 U.S. Code Sec.360bbb-3(e)(1)(A)(ii)(III), “authorization for medical products for use in emergencies,” it is unlawful to deny someone a job or an education because they refuse to be an experimental subject. Instead, potential recipients have an absolute right to refuse EUA vaccines.
U.S. laws, however, permit employers and schools to require students and workers to take licensed vaccines.
EUA-approved COVID vaccines have an extraordinary liability shield under the 2005 Public Readiness and Preparedness Act. Vaccine manufacturers, distributors, providers and government planners are immune from liability. The only way an injured party can sue is if he or she can prove willful misconduct, and if the U.S. government has also brought an enforcement action against the party for willful misconduct. No such lawsuit has ever succeeded.
Since Dec. 11, 2020, the Pfizer-BioNTech COVID-19 Vaccine has been available under the Food and Drug Administration’s Emergency Use Authorization in individuals 16 years of age and older, and the authorization was expanded to include those 12 through 15 years of age on May 10, 2021. On August 23, 2021, it was granted full approval by the FDA.
The Pfizer-BioNTech COVID-19 Vaccine now becomes the fastest created, deployed and subsequently approved vaccination in history. Previously, the fastest vaccine to go from development to deployment was the mumps vaccine in the 1960s, which took about four years.
The swift approval of the vaccine illustrates just how fast the government can react if it wants to do so. On the contrary, however, there have been hundreds if not thousands of studies on the benefits of cannabis to safely treat multiple ailments and diseases, spanning the course of centuries, yet the FDA has failed to approve its use for anything.
To be clear, the FDA has approved patentable pharmaceutical synthetic compounds such as dronabinol. The pharmaceutical patented drugs Marinol and Syndros both use dronabinol which is nothing more than a chemical synthetic equivalent to delta-9- tetrahydrocannabinol (THC) — but the plant-based version you can grow in your own home remains off the list.
On Monday, the FDA announced that it had approved the Pfizer-BioNTech COVID-19 vaccine for the prevention of the disease in individuals 16 years of age and older, but the rushed nature of their announcement raises questions.
Liberal media hacks rejoiced and gleefully spread the news they had been waiting for since Trump left office and the vaccine magically transformed into their only hope for mankind.
“Time for mandates!” They exclaimed, in some form or another, as they feverishly began plotting how they could now call for conservatives to be held down while a needle gets jammed in their arm.
And how convenient, just in time for booster shots!
The tyrants in Biden’s regime also jumped at the news and immediately said they would force all active-duty military members to get the jab. They are expected to implement even more draconian restrictions now that the FDA has given the experimental and highly controversial mRNA vaccine their ‘blessing.’
Seventy-one of the 222 drugs approved in the first decade of the millennium were withdrawn, required a “black box” warning on side effects or warranted a safety announcement about new risks, Dr. Joseph Ross, an associate professor of medicine at Yale School of Medicine, and colleagues reported in JAMA on Tuesday. The study included safety actions through Feb. 28.
“While the administration pushes for less regulation and faster approvals, those decisions have consequences,” Ross says. The Yale researchers’ previous studies concluded that the FDA approves drugs faster than its counterpart agency in Europe does and that the majority of pivotal trials in drug approvals involved fewer than 1,000 patients and lasted six months or less.
It took a median of 4.2 years after the drugs were approved for these safety concerns to come to light, the study found, and issues were more common among psychiatric drugs, biologic drugs, drugs that were granted “accelerated approval” and drugs that were approved near the regulatory deadline for approval.